We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





AI-Assisted Technology Platform to Be Used in Hunt for Most Effective COVID-19 Treatments

By HospiMedica International staff writers
Posted on 16 Jul 2020
New tools for automated network meta-analysis are now being used in the hunt for the most effective treatments for COVID-19.

Doctor Evidence (DRE Santa Monica, CA, USA), a Software-as-a-Service (SaaS) company in the AI-enabled health technology marketplace, is offering its DOC Analytics platform for real time aggregation of all the clinical trial data that is continuously emerging.

Currently, about 1,798 COVID-19 treatment trials are underway across the world and preliminary results and data from high-profile trials are now available, including for Remdesivir, Dexamethasone, and Hydroxychloroquine. More...
DRE is using its first-in-industry DOC Analytics platform to generate real-time network meta-analysis for researchers to produce quantitative analysis for any therapeutic question in the global landscape. This approach will inform decision-makers with regard to real-time updates from clinical trials for quantitative comparison, analysis, and reporting on relevant outcomes.

This novel quantitative analytic approach leverages DRE’s open DOC Search platform for COVID-19, which makes available annotated set of literature from CORD19, the open research dataset made available by the Allen Institute in response to the White House Task Force call to action in late March. DOC Search provides the foundation of medical conceptual organization to identify which key concepts are being reported across literature and trials.

“We are breaking new ground in AI-assisted technology at a critical time for healthcare,” said Bob Battista, MBA, FRCPH, FRCP Edin., Co-founder and Chief Executive Officer of DRE. “Our industry-first automated network meta-analysis technology and AI-enabled search engine are being utilized for rapid assessment of drug candidates for COVID-19. DOC Search and Analytics are being used as a foundational tool by top 10 industry ranked global pharmaceutical/life science companies that are DRE clients.”

Related Links:
Doctor Evidence


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Desk Aneroid Sphyg
Diagnostix 750D+
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Restrata Matrix and Solventum V.A.C. Therapy brings two advanced technologies together into one path to support active wound healing. (Photo courtesy of Solventum)

Combined Wound Healing Approach Pairs Synthetic Scaffold With Negative Pressure Therapy

Managing complex wounds requires both structural support for tissue repair and a controlled environment that protects the healing process. Frequent dressing changes can disrupt the wound bed and add complexity... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

AI Model Detects Hidden Disease Signals in Routine CT Scans

Computed tomography (CT) scans are often performed to answer a specific diagnostic question, which can leave other potentially important findings outside the immediate clinical focus. As a result, opportunities... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.